India aims to check drug reaction risk by reporting ‘near-misses’
The Indian health ministry's initiative aims to proactively record near misses in drug administration to prevent adverse reactions, improving patient safety and aligning with global standards. Enhanced reporting will identify systemic risks and improve healthcare delivery.
India is set to enhance its drug safety monitoring system by implementing a proactive approach, moving from largely reactive reporting to recording "near misses" involving potentially dangerous drug reactions. This initiative aims to identify recurring risks and issue timely safety alerts, according to two government officials and a document reviewed by Mint.
The proposed national framework will require healthcare professionals to document instances of risky drug combinations, allergies, and dosing errors, enabling regulators to take preventive measures before these issues affect patients. Priyanka Sharma, a journalist at Mint, reports on the Union Ministry of Health and the pharmaceutical industry, with a focus on explaining government policies and their impact on healthcare and the medicine market in India.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
